Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A device that remotely monitors the sleep patterns, breathing, and gait of people with Crohn's disease can identify increased disease activity prior to it being clinically evident, say researchers.
The anti-amyloid hopeful markedly reduced brain amyloid plaque and significantly slowed cognitive and functional decline in adults with early AD in the TRAILBLAZER-ALZ 2 trial.
Emerging biomarkers and treatments offer more options to diagnose and manage Alzheimer's disease.
An expert panel recommended restricting the expanded first-line indication to patients whose metastatic castration-resistant prostate tumors have BRCA mutations.
Use of ALZ-801, an optimized prodrug of tramiprosate, led to a significant reduction of plasma p-tau181, slowing of hippocampal atrophy, and stabilization of cognition in a phase 2 trial.